Common data elements for traumatic brain injury: recommendations from the biospecimens and biomarkers working group

Recent advances in genomics, proteomics, and biotechnology have provided unprecedented opportunities for translational research and personalized medicine. Human biospecimens and biofluids represent an important resource from which molecular data can be generated to detect and classify injury and to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Manley, Geoffrey T. (VerfasserIn) , Diaz-Arrastia, Ramon (VerfasserIn) , Brophy, Mary (VerfasserIn) , Engel, Doortje C. (VerfasserIn) , Goodman, Clay (VerfasserIn) , Gwinn, Katrina (VerfasserIn) , Veenstra, Timothy D. (VerfasserIn) , Ling, Geoffrey (VerfasserIn) , Ottens, Andrew K. (VerfasserIn) , Tortella, Frank (VerfasserIn) , Hayes, Ronald L. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 31 October 2010
In: Archives of physical medicine and rehabilitation
Year: 2010, Jahrgang: 91, Heft: 11, Pages: 1667-1672
ISSN:1532-821X
DOI:10.1016/j.apmr.2010.05.018
Online-Zugang:lizenzpflichtig
lizenzpflichtig
Volltext
Verfasserangaben:Geoffrey T. Manley, Ramon Diaz-Arrastia, Mary Brophy, Doortje Engel, Clay Goodman, Katrina Gwinn, Timothy D. Veenstra, Geoffrey Ling, Andrew K. Ottens, Frank Tortella, Ronald L. Hayes
Beschreibung
Zusammenfassung:Recent advances in genomics, proteomics, and biotechnology have provided unprecedented opportunities for translational research and personalized medicine. Human biospecimens and biofluids represent an important resource from which molecular data can be generated to detect and classify injury and to identify molecular mechanisms and therapeutic targets. To date, there has been considerable variability in biospecimen and biofluid collection, storage, and processing in traumatic brain injury (TBI) studies. To realize the full potential of this important resource, standardization and adoption of best practice guidelines are required to insure the quality and consistency of these specimens. The aim of the Biospecimens and Biomarkers Working Group was to provide recommendations for core data elements for TBI research and develop best practice guidelines to standardize the quality and accessibility of these specimens.
Beschreibung:Gesehen am 04.05.2023
Beschreibung:Online Resource
ISSN:1532-821X
DOI:10.1016/j.apmr.2010.05.018